-
Loading metrics
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
- Tom Callender,
- Mark Emberton,
- Steve Morris,
- Ros Eeles,
- Zsofia Kote-Jarai,
- Paul D. P. Pharoah,
- Nora Pashayan
![PLOS](/resource/img/logo-plos.png)
x
- Published: December 20, 2019
- https://doi.org/10.1371/journal.pmed.1002998